allogeneic mesenchymal stromal cells / Pandorum Tech, Medical University of South Carolina - LARVOL DELTA

SAMPSON-1: Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: Medical University of South Carolina | N=10 ➔ 0 | Trial completion date: May 2027 ➔ Oct 2024 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Dec 2026 ➔ Oct 2024

Enrollment change • Stroma • Trial completion date • Trial primary completion date • Trial withdrawal • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases

SAMPSON-1: Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias (clinicaltrials.gov) - P1 | N=10 | Not yet recruiting | Sponsor: Medical University of South Carolina

Stroma • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases

SAMPSON-1: Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias (clinicaltrials.gov) - P1 | N=10 | Not yet recruiting | Sponsor: Medical University of South Carolina | Trial completion date: May 2023 ➔ May 2026 | Trial primary completion date: May 2023 ➔ Dec 2025

Stroma • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases